Boehringer Ingelheim BioXcellence and Sutro Biopharma (STRO) announced that they successfully applied Sutro’s proprietary cell-free expression technology on a commercial scale to manufacture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback